MAPT and Alzheimer disease: Several studies showed that Aβ directly binds to and competitively inhibits the proteasome, leading to toxic accumulation of Tau and Aβ (124, 125), while other studies suggested proteasome inhibition occurs due to an elevation in oxidative stress in AD (126, 127, 128, 129).